Cargando…
Epigenetic regulatory mechanism of ADAMTS12 expression in osteoarthritis
BACKGROUND: Osteoarthritis (OA) is a degenerative joint disease with lacking effective prevention targets. A disintegrin and metalloproteinase with thrombospondin motifs 12 (ADAMTS12) is a member of the ADAMTS family and is upregulated in OA pathologic tissues with no fully understood molecular mech...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10318776/ https://www.ncbi.nlm.nih.gov/pubmed/37400752 http://dx.doi.org/10.1186/s10020-023-00661-2 |
_version_ | 1785068112341630976 |
---|---|
author | Yang, Shu Zhou, Xuanping Jia, Zhen Zhang, Mali Yuan, Minghao Zhou, Yizhao Wang, Jing Xia, Duo |
author_facet | Yang, Shu Zhou, Xuanping Jia, Zhen Zhang, Mali Yuan, Minghao Zhou, Yizhao Wang, Jing Xia, Duo |
author_sort | Yang, Shu |
collection | PubMed |
description | BACKGROUND: Osteoarthritis (OA) is a degenerative joint disease with lacking effective prevention targets. A disintegrin and metalloproteinase with thrombospondin motifs 12 (ADAMTS12) is a member of the ADAMTS family and is upregulated in OA pathologic tissues with no fully understood molecular mechanisms. METHODS: The anterior cruciate ligament transection (ACL-T) method was used to establish rat OA models, and interleukin-1 beta (IL-1β) was administered to induce rat chondrocyte inflammation. Cartilage damage was analyzed via hematoxylin-eosin, Periodic Acid-Schiff, safranin O-fast green, Osteoarthritis Research Society International score, and micro-computed tomography assays. Chondrocyte apoptosis was detected by flow cytometry and TdT dUTP nick-end labeling. Signal transducer and activator of transcription 1 (STAT1), ADAMTS12, and methyltransferase-like 3 (METTL3) levels were detected by immunohistochemistry, quantitative polymerase chain reaction (qPCR), western blot, or immunofluorescence assay. The binding ability was confirmed by chromatin immunoprecipitation-qPCR, electromobility shift assay, dual-luciferase reporter, or RNA immunoprecipitation (RIP) assay. The methylation level of STAT1 was analyzed by MeRIP-qPCR assay. STAT1 stability was investigated by actinomycin D assay. RESULTS: The STAT1 and ADAMTS12 expressions were significantly increased in the human and rat samples of cartilage injury, as well as in IL-1β-treated rat chondrocytes. STAT1 is bound to the promoter region of ADAMTS12 to activate its transcription. METTL3/ Insulin-like growth factor 2 mRNA-binding protein 2 (IGF2BP2) mediated N6-methyladenosine modification of STAT1 promoted STAT1 mRNA stability, resulting in increased expression. ADAMTS12 expression was reduced and the IL-1β-induced inflammatory chondrocyte injury was attenuated by silencing METTL3. Additionally, knocking down METTL3 in ACL-T-produced OA rats reduced ADAMTS12 expression in their cartilage tissues, thereby alleviating cartilage damage. CONCLUSION: METTL3/IGF2BP2 axis increases STAT1 stability and expression to promote OA progression by up-regulating ADAMTS12 expression. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s10020-023-00661-2. |
format | Online Article Text |
id | pubmed-10318776 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-103187762023-07-05 Epigenetic regulatory mechanism of ADAMTS12 expression in osteoarthritis Yang, Shu Zhou, Xuanping Jia, Zhen Zhang, Mali Yuan, Minghao Zhou, Yizhao Wang, Jing Xia, Duo Mol Med Research Article BACKGROUND: Osteoarthritis (OA) is a degenerative joint disease with lacking effective prevention targets. A disintegrin and metalloproteinase with thrombospondin motifs 12 (ADAMTS12) is a member of the ADAMTS family and is upregulated in OA pathologic tissues with no fully understood molecular mechanisms. METHODS: The anterior cruciate ligament transection (ACL-T) method was used to establish rat OA models, and interleukin-1 beta (IL-1β) was administered to induce rat chondrocyte inflammation. Cartilage damage was analyzed via hematoxylin-eosin, Periodic Acid-Schiff, safranin O-fast green, Osteoarthritis Research Society International score, and micro-computed tomography assays. Chondrocyte apoptosis was detected by flow cytometry and TdT dUTP nick-end labeling. Signal transducer and activator of transcription 1 (STAT1), ADAMTS12, and methyltransferase-like 3 (METTL3) levels were detected by immunohistochemistry, quantitative polymerase chain reaction (qPCR), western blot, or immunofluorescence assay. The binding ability was confirmed by chromatin immunoprecipitation-qPCR, electromobility shift assay, dual-luciferase reporter, or RNA immunoprecipitation (RIP) assay. The methylation level of STAT1 was analyzed by MeRIP-qPCR assay. STAT1 stability was investigated by actinomycin D assay. RESULTS: The STAT1 and ADAMTS12 expressions were significantly increased in the human and rat samples of cartilage injury, as well as in IL-1β-treated rat chondrocytes. STAT1 is bound to the promoter region of ADAMTS12 to activate its transcription. METTL3/ Insulin-like growth factor 2 mRNA-binding protein 2 (IGF2BP2) mediated N6-methyladenosine modification of STAT1 promoted STAT1 mRNA stability, resulting in increased expression. ADAMTS12 expression was reduced and the IL-1β-induced inflammatory chondrocyte injury was attenuated by silencing METTL3. Additionally, knocking down METTL3 in ACL-T-produced OA rats reduced ADAMTS12 expression in their cartilage tissues, thereby alleviating cartilage damage. CONCLUSION: METTL3/IGF2BP2 axis increases STAT1 stability and expression to promote OA progression by up-regulating ADAMTS12 expression. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s10020-023-00661-2. BioMed Central 2023-07-03 /pmc/articles/PMC10318776/ /pubmed/37400752 http://dx.doi.org/10.1186/s10020-023-00661-2 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Research Article Yang, Shu Zhou, Xuanping Jia, Zhen Zhang, Mali Yuan, Minghao Zhou, Yizhao Wang, Jing Xia, Duo Epigenetic regulatory mechanism of ADAMTS12 expression in osteoarthritis |
title | Epigenetic regulatory mechanism of ADAMTS12 expression in osteoarthritis |
title_full | Epigenetic regulatory mechanism of ADAMTS12 expression in osteoarthritis |
title_fullStr | Epigenetic regulatory mechanism of ADAMTS12 expression in osteoarthritis |
title_full_unstemmed | Epigenetic regulatory mechanism of ADAMTS12 expression in osteoarthritis |
title_short | Epigenetic regulatory mechanism of ADAMTS12 expression in osteoarthritis |
title_sort | epigenetic regulatory mechanism of adamts12 expression in osteoarthritis |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10318776/ https://www.ncbi.nlm.nih.gov/pubmed/37400752 http://dx.doi.org/10.1186/s10020-023-00661-2 |
work_keys_str_mv | AT yangshu epigeneticregulatorymechanismofadamts12expressioninosteoarthritis AT zhouxuanping epigeneticregulatorymechanismofadamts12expressioninosteoarthritis AT jiazhen epigeneticregulatorymechanismofadamts12expressioninosteoarthritis AT zhangmali epigeneticregulatorymechanismofadamts12expressioninosteoarthritis AT yuanminghao epigeneticregulatorymechanismofadamts12expressioninosteoarthritis AT zhouyizhao epigeneticregulatorymechanismofadamts12expressioninosteoarthritis AT wangjing epigeneticregulatorymechanismofadamts12expressioninosteoarthritis AT xiaduo epigeneticregulatorymechanismofadamts12expressioninosteoarthritis |